生物製藥(生物醫藥品)的全球市場的預測(2022年~2032年):各產品類型,各適應症,各製造,主要國家市場分析,主要企業,COVID-19
市場調查報告書
商品編碼
1100181

生物製藥(生物醫藥品)的全球市場的預測(2022年~2032年):各產品類型,各適應症,各製造,主要國家市場分析,主要企業,COVID-19

Biologics Market Report 2022-2032: Forecasts by Product Type (Monoclonal Antibodies, Vaccines, Protein Therapeutics, Fusion Proteins, Regenerative Medicine), by Application, by Manufacturing, Leading National Market Analysis & Companies, COVID-19

出版日期: | 出版商: Visiongain Reports Ltd. | 英文 475 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物製藥(生物醫藥品)市場收益全體,預計2022年超過3,828億5,000萬美元,到2032年強力成長。

本報告提供全球生物製藥(生物醫藥品)市場相關調查分析,市場市場動態,各市場區隔的市場預測,各地區的市場預測,競爭情形等相關之最新資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • SWOT分析
  • 波特的五力分析
  • PEST分析

第4章 生物製藥(生物醫藥品)市場預測:各產品類型(2022年~2032年)

  • 單株抗體
  • 疫苗
  • 蛋白質治療
  • 再生醫療
  • 融合蛋白質

第5章 生物製藥(生物醫藥品)市場預測:各適應症(2022年~2032年)

  • 腫瘤
  • 自體免疫疾病
  • 感染疾病
  • 心血管疾病
  • 血液疾病
  • 其他

第6章 生物製藥(生物醫藥品)市場預測:各製造(2022年~2032年)

  • 自家公司
  • 外包

第7章 全球生物製藥(生物醫藥品)市場預測(2022年~2032年)

  • 全球生物製藥(生物醫藥品)市場預測:各地區
  • 復甦情境(V,U,W,L)

第8章 北美的生物製藥(生物醫藥品)市場(2022年~2032年)

  • 全球生物製藥(生物醫藥品)市場上北美獲得的最大佔有率
  • 北美的生物製藥(生物醫藥品)市場預測:各國
  • 北美的生物製藥(生物醫藥品)市場預測:各產品類型
  • 北美的生物製藥(生物醫藥品)市場預測:各適應症
  • 北美的生物製藥(生物醫藥品)市場預測:各製造
  • 美國的生物製藥(生物醫藥品)市場預測
  • 加拿大的生物製藥(生物醫藥品)市場預測

第9章 歐洲的生物製藥(生物醫藥品)市場(2022年~2032年)

第10章 亞太地區的生物製藥(生物醫藥品)市場(2022年~2032年)

第11章 南美的生物製藥(生物醫藥品)市場(2022年~2032年)

第12章 中東、非洲的生物製藥(生物醫藥品)市場(2022年~2032年)

第13章 企業簡介

  • 企業佔有率分析
  • 生物製藥(生物醫藥品)市場最近的趨勢
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • GlaxoSmithKline plc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi
  • Novo Holdings A/S (Novo Nordisk A/S)
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Biogen
  • NuVasive, Inc.
  • ORTHOFIX INTERNATIONAL N.V.
  • Organogenesis Holdings Inc.
  • AbbVie Inc.

第14章 結論、建議

Product Code: PHA1177

Title:
Biologics Market Report 2022-2032
Forecasts by Product Type (Monoclonal Antibodies, Vaccines, Protein Therapeutics Fusion Proteins and Regenerative Medicine), by Application (Oncology, Autoimmune Disorder, Infectious Diseases, Cardiovascular Disorders, Hematological Disorders, Others), by Manufacturing (Outsourced, In-house) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

The Biologics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Active R&D and Focus on Clinical Trials is Boosting the Biologics Market Growth

Active R&D and focus on clinical trials is driving the global biologics market growth. These R&D operations have resulted in increased success rates in biologic clinical studies. Industry leaders in the biologics market do R&D as they strive to produce market innovations in the form of effective and innovative biologics. Companies in the biologics sector have huge profit margins because of the high pricing of biologics and their efficacy. For decades, pharmaceutical corporations have focused on small compounds, but the rate of discovery in that sector has slowed drastically, resulting in a move toward biologics. Biologics therapy, which is roughly 20 times more expensive than small molecules, is predicted to create a profit margin of about 40%-45% in the future.

Logistical and Administrative Challenges

Governments and regulatory agencies play important roles in the biologics sector. Regulatory bodies maintain regulatory procedures for the development of new biologics markets for both existing and novel pharmaceuticals. Over the last decade, drug researchers have faced an increasing pushback in major markets for clinical studies of innovative biologics, which has hindered the launch of novel treatments for rare diseases. Strategic measures have been taken in these large markets, such as the United States and the European Union, to strengthen and liberalise regulatory regulations, hence simplifying clinical trial design. However, an increase in government spending for drug-related healthcare programmes is critical to industry success.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the biologics market evolving?
  • What is driving and restraining the biologics market?
  • How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each biologics submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the biologics projects for these leading companies?
  • How will the industry evolve during the period between 2022 and 2032? What is the implication of biologics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the biologics market?
  • Where is the biologics market heading? And how can you ensure you are at the forefront of the market?
  • What can be the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biologics market today, and over the next 10 years:

  • Our 475-page report provides 308 tables and 320 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • Contains in-depth analysis of global, regional and national sales and growth
  • Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the biologics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V" , "L" , "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product Type

  • Monoclonal Antibodies
  • Vaccines
  • Protein Therapeutics
  • Fusion Proteins
  • Regenerative Medicine

Application

  • Oncology
  • Autoimmune Disorder
  • Infectious Diseases
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others

Manufacturing

  • Outsourced
  • In-house

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Biologics Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis AG
  • NuVasive, Inc.
  • Novo Holdings A/S (Novo Nordisk A/S)
  • Organogenesis Holdings Inc.
  • ORTHOFIX INTERNATIONAL N.V.
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Overall world revenue for Biologics Market, 2022 to 2032 in terms of value the market will surpass US$382.85 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biologics Market, 2022 to 2032 Market report helps you?

In summary, our 470+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Biologics Market, 2022 to 2032 Market, with forecasts for product type, application, and manufacturing each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2032 for 5 regional and 22 key national markets - See forecasts for the Biologics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 18 of the major companies involved in the Biologics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our new report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biologics Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Introduction to Biologics Market
  • 1.2. Biologics Market Definition
  • 1.3. Why You Should Read This Report
  • 1.4. What This Report Delivers
  • 1.5. Key Questions Answered By This Analytical Report Include:
  • 1.6. Who is This Report For?
  • 1.7. Methodology
    • 1.7.1. Primary Research
    • 1.7.2. Secondary Research
    • 1.7.3. Market Evaluation & Forecasting Methodology
  • 1.8. Frequently Asked Questions (FAQs)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Executive Summary

3. Market Dynamics

  • 3.1. Drivers
    • 3.1.1. Advancements in Biomedical Science
    • 3.1.2. Increasing Funding for the Development of Novel Biologic Drugs
    • 3.1.3. Several Drugs Going Off Patents
  • 3.2. Restraints
    • 3.2.1. High Stringency and Low Turnover for Clinical Trials
    • 3.2.2. Development of Biosimilars will Reduce the Demand for Biological Drugs
  • 3.3. Opportunities
    • 3.3.1. Biologic Therapies are Becoming Relevant in a Greater Number of Disease Areas
  • 3.4. Challenges
    • 3.4.1. Complexity in Development of Biologics
  • 3.5. SWOT Analysis
    • 3.5.1. Strengths
      • 3.5.1.1. Rising Need for Effective biologics Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
    • 3.5.2. Weaknesses
      • 3.5.2.1. Financial Loss Due To Innovative Biologics Failure Has Been a Perennial Problem
    • 3.5.3. Opportunities
      • 3.5.3.1. Strong pipeline products and huge number of ongoing clinical trials are providing market growth opportunity.
      • 3.5.3.2. Application of Nanotechnology in future
    • 3.5.4. Threats
      • 3.5.4.1. Small Molecules
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Supplier: High
    • 3.6.2. Bargaining Power of Buyers: Moderate
    • 3.6.3. Competitive Rivalry: High
    • 3.6.4. Threat of New Entrants: Moderate
    • 3.6.5. Threat of Substitutes: Low
  • 3.7. PEST Analysis
    • 3.7.1. Political Factors Impacting Biologics Market
    • 3.7.2. Economic Factors Impacting Biologics Market
    • 3.7.3. Social Factors Impacting Biologics Market
    • 3.7.4. Technological Factors Impacting Biologics Market

4. Biologics Market by Product Type Forecast, 2022-2032

  • 4.1. Monoclonal Antibodies Segment Market Forecast, 2022-2032
    • 4.1.1. Monoclonal Antibodies: Holds Largest Market Share
    • 4.1.2. Recovery Scenarios (V, U, W, L)
  • 4.2. Vaccine Segment Market Forecast, 2022-2032
    • 4.2.1. Vaccine Manufacturing Remains Concentrated, With Four Large Manufacturers
    • 4.2.2. Recovery Scenarios (V, U, W, L)
  • 4.3. Protein Therapeutics Segment Market Forecast, 2022-2032
    • 4.3.1. Increased public knowledge of the benefits of protein therapies
    • 4.3.2. Recovery Scenarios (V, U, W, L)
  • 4.4. Regenerative Medicines Segment Market Forecast, 2022-2032
    • 4.4.1. Government policies favouring Regenerative Medicines
    • 4.4.2. Recovery Scenarios (V, U, W, L)
  • 4.5. Fusion Proteins Segment Market Forecast, 2022-2032
    • 4.5.1. Rising prevalence of diabetes expected to boost demand of fusion proteins
    • 4.5.2. Recovery Scenarios (V, U, W, L)

5. Biologics Market by Application Forecast, 2022-2032

  • 5.1. Oncology Segment Market Forecast, 2022-2032
    • 5.1.1. Biological cancer therapy aims to train the immune system to recognise and kill cancer cells
    • 5.1.2. Recovery Scenarios (V, U, W, L)
  • 5.2. Autoimmune Diseases Segment Market Forecast, 2022-2032
    • 5.2.1. Increasing Research and Development in this segment
    • 5.2.2. Recovery Scenarios (V, U, W, L)
  • 5.3. Infectious Diseases Therapeutics Segment Market Forecast, 2022-2032
    • 5.3.1. Possible alternative to oral and parenteral routes of administration
    • 5.3.2. Recovery Scenarios (V, U, W, L)
  • 5.4. Cardiovascular Diseases Segment Market Forecast, 2022-2032
    • 5.4.1. Cardiovascular Disorders is becoming the top cause of death worldwide
    • 5.4.2. Recovery Scenarios (V, U, W, L)
  • 5.5. Haematological Disorders Segment Market Forecast, 2022-2032
    • 5.5.1. Blood disorders became a worldwide health issue
    • 5.5.2. Recovery Scenarios (V, U, W, L)
  • 5.6. Others Segment Market Forecast, 2022-2032
    • 5.6.1. Adoption Haematological Disorders Technologies is expected to boost the Others Segment Growth
    • 5.6.2. Recovery Scenarios (V, U, W, L)

6. Biologics Market by Manufacturing Forecast, 2022-2032

  • 6.1. In-house Segment Market Forecast, 2022-2032
    • 6.1.1. In-house holds largest Revenue market share
    • 6.1.2. Recovery Scenarios (V, U, W, L)
  • 6.2. Outsourced Segment Market Forecast, 2022-2032
    • 6.2.1. Ease of use of Topical drug delivery to boost the outsourced market
    • 6.2.2. Recovery Scenarios (V, U, W, L)

7. Global Biologics Market Forecast, 2022-2032

  • 7.1. Global Biologics Market by Region Forecast 2022-2032
  • 7.2. Recovery Scenarios (V, U, W, L)

8. North America Biologics Market, 2022-2032

  • 8.1. Largest share acquired by North America in Global Biologics Market
  • 8.2. North America Biologics Market by Country, Forecast 2022-2032
  • 8.3. North America Biologics Market Forecast by Product Type
    • 8.3.1. Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2022-2032
  • 8.4. North America Biologics Market Forecast by Application
    • 8.4.1. Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2022-2032
  • 8.5. North America Biologics Market Forecast by Manufacturing
    • 8.5.1. Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2022-2032
  • 8.6. U.S. Biologics Market Forecast, 2022-2032
    • 8.6.1. Growing public and private funding for research studies in this region
    • 8.6.2. Budget request for Pandemic preparedness
    • 8.6.3. Recovery Scenarios (V, U, W, L): U.S. Biologics Market Forecast, 2022-2032
  • 8.7. Canada Biologics Market Forecast, 2022-2032
    • 8.7.1. Growing Prevalence of Psoriasis and Related Research and Development across the Region
    • 8.7.2. Biologics represent a large segment of drug spending in Canada
    • 8.7.3. Recovery Scenarios (V, U, W, L): Canada Biologics Market Forecast, 2022-2032

9. Europe Biologics Market, 2022-2032

  • 9.1. Launch of Advanced Biologics across the Region
  • 9.2. Europe Biologics Market by Country, Forecast 2022-2032
  • 9.3. Europe Biologics Market Forecast by Product Type
    • 9.3.1. Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Product Type, 2022-2032
  • 9.4. Europe Biologics Market Forecast by Application
    • 9.4.1. Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2022-2032
  • 9.5. Europe Biologics Market Forecast by Manufacturing
    • 9.5.1. Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2022-2032
  • 9.6. Germany Biologics Market Forecast, 2022-2032
    • 9.6.1. German government support market player for product development
    • 9.6.2. Recovery Scenarios (V, U, W, L): Germany Biologics Market Forecast, 2022-2032
  • 9.7. U.K. Biologics Market Forecast, 2022-2032
    • 9.7.1. Increase in prevalence of diabetes and skin conditions
    • 9.7.2. Recovery Scenarios (V, U, W, L): U.K. Biologics Market Forecast, 2022-2032
  • 9.8. France Biologics Market Forecast, 2022-2032
    • 9.8.1. Growing cancer prevalence and French government cancer control strategy
    • 9.8.2. Recovery Scenarios (V, U, W, L): France Biologics Market Forecast, 2022-2032
  • 9.9. Italy Biologics Market Forecast, 2022-2032
    • 9.9.1. Rising prevalence of cancer
    • 9.9.2. Recovery Scenarios (V, U, W, L): Italy Biologics Market Forecast, 2022-2032
  • 9.10. Spain Biologics Market Forecast, 2022-2032
    • 9.10.1. Growing burden of Infectious diseases
    • 9.10.2. Recovery Scenarios (V, U, W, L): Spain Biologics Market Forecast, 2022-2032
  • 9.11. Russia Biologics Market Forecast, 2022-2032
    • 9.11.1. Major leap forward in terms of Digitalization
    • 9.11.2. Recovery Scenarios (V, U, W, L): Russia Biologics Market Forecast, 2022-2032
  • 9.12. Rest of Europe Biologics Market Forecast, 2022-2032
    • 9.12.1. Rising Adoption of Advanced Biologics
    • 9.12.2. Recovery Scenarios (V, U, W, L): Rest of Europe Biologics Market Forecast, 2022-2032

10. Asia Pacific Biologics Market, 2022-2032

  • 10.1. Biologics APAC will emerge as the fastest growing regional market for biologics market R&D and production
  • 10.2. Asia Pacific Biologics Market by Country, Forecast 2022-2032
  • 10.3. Asia Pacific Biologics Market Forecast by Product Type
    • 10.3.1. Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Product Type, 2022-2032
  • 10.4. Asia Pacific Biologics Market Forecast by Application
    • 10.4.1. Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Application, 2022-2032
  • 10.5. Asia Pacific Biologics Market Forecast by Manufacturing
    • 10.5.1. Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032
  • 10.6. Japan Biologics Market Forecast, 2022-2032
    • 10.6.1. Major market players investing on R&D
    • 10.6.2. Recovery Scenarios (V, U, W, L): Japan Biologics Market Forecast, 2022-2032
  • 10.7. China Biologics Market Forecast, 2022-2032
    • 10.7.1. Rapid growth of Domestic mAb pipeline and regulatory reform is creating business opportunities for Biologics CDMO's in China
    • 10.7.2. Recovery Scenarios (V, U, W, L): China Biologics Market Forecast, 2022-2032
  • 10.8. India Biologics Market Forecast, 2022-2032
    • 10.8.1. India Biologics market currently is dominated by Simple Biologics
    • 10.8.2. Recovery Scenarios (V, U, W, L): India Biologics Market Forecast, 2022-2032
  • 10.9. Australia Biologics Market Forecast, 2022-2032
    • 10.9.1. Growing capital investment by the market player
    • 10.9.2. Recovery Scenarios (V, U, W, L): Australia Biologics Market Forecast, 2022-2032
  • 10.10. South Korea Biologics Market Forecast, 2022-2032
    • 10.10.1. Increasing prevalence of Cancer in South Korea
    • 10.10.2. Recovery Scenarios (V, U, W, L): South Korea Biologics Market Forecast, 2022-2032
  • 10.11. Rest of Asia Pacific Biologics Market Forecast, 2022-2032
    • 10.11.1. Rising Disposable Income in this region
    • 10.11.2. Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biologics Market Forecast, 2022-2032

11. Latin America Biologics Market, 2022-2032

  • 11.1. Latin America Biologics Market expected to grow at lucrative CAGR
  • 11.2. Latin America Biologics Market by Country, Forecast 2022-2032
  • 11.3. Latin America Biologics Market Forecast by Product Type
    • 11.3.1. Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2022-2032
  • 11.4. Latin America Biologics Market Forecast by Application
    • 11.4.1. Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2022-2032
  • 11.5. Latin America Biologics Market Forecast by Manufacturing
    • 11.5.1. Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2022-2032
  • 11.6. Brazil Biologics Market Forecast, 2022-2032
    • 11.6.1. High Potential Manufacturing Environment
    • 11.6.2. Recovery Scenarios (V, U, W, L): Brazil Biologics Market Forecast, 2022-2032
  • 11.7. Mexico Biologics Market Forecast, 2022-2032
    • 11.7.1. Lower Manufacturing Cost in Mexico
    • 11.7.2. Recovery Scenarios (V, U, W, L): Mexico Biologics Market Forecast, 2022-2032
  • 11.8. Rest of Latin America Biologics Market Forecast, 2022-2032
    • 11.8.1. Developing Healthcare Infrastructure in this region
    • 11.8.2. Recovery Scenarios (V, U, W, L): Rest of Latin America Biologics Market Forecast, 2022-2032

12. MEA Biologics Market, 2022-2032

  • 12.1. Increasing occurrence of Cancer in this region
  • 12.2. MEA Biologics Market by Country, Forecast 2022-2032
  • 12.3. MEA Biologics Market Forecast by Product Type
    • 12.3.1. Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Product Type, 2022-2032
  • 12.4. MEA Biologics Market Forecast by Application
    • 12.4.1. Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2022-2032
  • 12.5. MEA Biologics Market Forecast by Manufacturing
    • 12.5.1. Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Manufacturing, 2022-2032
  • 12.6. GCC Biologics Market Forecast, 2022-2032
    • 12.6.1. Presence of Hug Growth Opportunities
    • 12.6.2. Recovery Scenarios (V, U, W, L): GCC Biologics Market Forecast, 2022-2032
  • 12.7. South Africa Biologics Market Forecast, 2022-2032
    • 12.7.1. Rapidly increasing infectious diseases in this South Africa
    • 12.7.2. Recovery Scenarios (V, U, W, L): South Africa Biologics Market Forecast, 2022-2032
  • 12.8. Rest of MEA Biologics Market Forecast, 2022-2032
    • 12.8.1. Cancer is one of the main reason of Death causes in Rest of MEA
    • 12.8.2. Recovery Scenarios (V, U, W, L): Rest of MEA Biologics Market Forecast, 2022-2032

13. Company Profiles

  • 13.1. Company Share Analysis
  • 13.2. Biologics Market Recent Developments
  • 13.3. Johnson & Johnson Services, Inc.
    • 13.3.1. Company Snapshot
    • 13.3.2. Company Overview
    • 13.3.3. Financial Analysis
      • 13.3.3.1. Net Revenue, 2017-2021
      • 13.3.3.2. Regional Revenue/Market Shares, 2021
      • 13.3.3.3. Segmental Revenue/Market Shares, 2021
    • 13.3.4. Product Benchmarking
    • 13.3.5. Recent Developments
  • 13.4. Merck KGaA
    • 13.4.1. Company Snapshot
    • 13.4.2. Company Overview
    • 13.4.3. Financial Analysis
      • 13.4.3.1. Net Revenue, 2017-2021
      • 13.4.3.2. Regional Revenue/Market Shares, 2021
      • 13.4.3.3. Segmental Revenue/Market Shares, 2021
    • 13.4.4. Product Benchmarking
    • 13.4.5. Recent Developments
  • 13.5. GlaxoSmithKline plc.
    • 13.5.1. Company Snapshot
    • 13.5.2. Company Overview
    • 13.5.3. Financial Analysis
      • 13.5.3.1. Net Revenue, 2017-2021
      • 13.5.3.2. Regional Revenue/Market Shares, 2021
      • 13.5.3.3. Segmental Revenue/Market Shares, 2021
    • 13.5.4. Product Benchmarking
    • 13.5.5. Recent Developments
  • 13.6. Novartis AG
    • 13.6.1. Company Snapshot
    • 13.6.2. Company Overview
    • 13.6.3. Financial Analysis
      • 13.6.3.1. Net Revenue, 2017-2021
      • 13.6.3.2. Regional Revenue/Market Shares, 2021
      • 13.6.3.3. Segmental Revenue/Market Shares, 2021
    • 13.6.4. Product Benchmarking
    • 13.6.5. Recent Developments
  • 13.7. F. Hoffmann-La Roche Ltd
    • 13.7.1. Company Snapshot
    • 13.7.2. Company Overview
    • 13.7.3. Financial Analysis
      • 13.7.3.1. Net Revenue, 2017-2021
      • 13.7.3.2. Segmental Revenue/Market Shares, 2021
      • 13.7.3.3. Regional Revenue/Market Shares, 2020
    • 13.7.4. Product Benchmarking
    • 13.7.5. Recent Developments
  • 13.8. Pfizer Inc.
    • 13.8.1. Company Snapshot
    • 13.8.2. Company Overview
    • 13.8.3. Financial Analysis
      • 13.8.3.1. Net Revenue, 2017-2021
      • 13.8.3.2. Regional Revenue/Market Shares, 2021
      • 13.8.3.3. Segmental Revenue/Market Shares, 2021
    • 13.8.4. Product Benchmarking
    • 13.8.5. Recent Developments
  • 13.9. Sanofi
    • 13.9.1. Company Snapshot
    • 13.9.2. Company Overview
    • 13.9.3. Financial Analysis
      • 13.9.3.1. Net Revenue, 2017-2021
      • 13.9.3.2. Regional Revenue/Market Shares, 2021
      • 13.9.3.3. Segmental Revenue/Market Shares, 2021
    • 13.9.4. Product Benchmarking
    • 13.9.5. Recent Developments
  • 13.10. Novo Holdings A/S (Novo Nordisk A/S)
    • 13.10.1. Company Snapshot
    • 13.10.2. Company Overview
    • 13.10.3. Financial Analysis
      • 13.10.3.1. Net Revenue, 2017-2021
      • 13.10.3.2. Regional Revenue/Market Shares, 2020
      • 13.10.3.3. Segmental Revenue/Market Shares, 2020
    • 13.10.4. Product Benchmarking
    • 13.10.5. Recent Developments
  • 13.11. Takeda Pharmaceutical Company Limited
    • 13.11.1. Company Snapshot
    • 13.11.2. Company Overview
    • 13.11.3. Financial Analysis
      • 13.11.3.1. Net Revenue, 2017-2021
      • 13.11.3.2. Regional Revenue/Market Shares, 2020
      • 13.11.3.3. Segmental Revenue/Market Shares, 2020
    • 13.11.4. Product Benchmarking
  • 13.12. Eli Lilly and Company
    • 13.12.1. Company Snapshot
    • 13.12.2. Company Overview
    • 13.12.3. Financial Analysis
      • 13.12.3.1. Net Revenue, 2017-2021
      • 13.12.3.2. Regional Revenue/Market Shares, 2020
    • 13.12.4. Product Benchmarking
    • 13.12.5. Recent Developments
  • 13.13. Amgen Inc.
    • 13.13.1. Company Snapshot
    • 13.13.2. Company Overview
    • 13.13.3. Financial Analysis
      • 13.13.3.1. Net Revenue, 2017-2021
      • 13.13.3.2. Regional Revenue Shares, 2021
      • 13.13.3.3. Segment Revenue Shares, 2021
    • 13.13.4. Product Benchmarking
    • 13.13.5. Recent Developments
  • 13.14. Bristol-Myers Squibb Company
    • 13.14.1. Company Snapshot
    • 13.14.2. Company Overview
    • 13.14.3. Financial Analysis
      • 13.14.3.1. Net Revenue, 2017-2021
      • 13.14.3.2. Regional Revenue Shares, 2021
    • 13.14.4. Product Benchmarking
    • 13.14.5. Recent Developments
  • 13.15. Biogen
    • 13.15.1. Company Snapshot
    • 13.15.2. Company Overview
    • 13.15.3. Financial Analysis
      • 13.15.3.1. Net Revenue, 2017-2021
      • 13.15.3.2. Regional Revenue Shares, 2021
    • 13.15.4. Product Benchmarking
    • 13.15.5. Recent Developments
  • 13.16. NuVasive, Inc.
    • 13.16.1. Company Snapshot
    • 13.16.2. Company Overview
    • 13.16.3. Financial Analysis
      • 13.16.3.1. Net Revenue, 2017-2021
      • 13.16.3.2. Regional Revenue Shares, 2021
      • 13.16.3.3. Segment Revenue Shares, 2021
    • 13.16.4. Product Benchmarking
  • 13.17. ORTHOFIX INTERNATIONAL N.V.
    • 13.17.1. Company Snapshot
    • 13.17.2. Company Overview
    • 13.17.3. Financial Analysis
      • 13.17.3.1. Net Revenue, 2017-2021
      • 13.17.3.2. Regional Revenue Shares, 2021
      • 13.17.3.3. Segment Revenue Shares, 2020
    • 13.17.4. Product Benchmarking
  • 13.18. Organogenesis Holdings Inc.
    • 13.18.1. Company Snapshot
    • 13.18.2. Company Overview
    • 13.18.3. Financial Analysis
      • 13.18.3.1. Net Revenue, 2018-2021
      • 13.18.3.2. Segment Revenue Shares, 2021
    • 13.18.4. Product Benchmarking
  • 13.19. AbbVie Inc.
    • 13.19.1. Company Snapshot
    • 13.19.2. Company Overview
    • 13.19.3. Financial Analysis
      • 13.19.3.1. Net Revenue, 2017-2021
      • 13.19.3.2. Regional Revenue Shares, 2021
      • 13.19.3.3. Segment Revenue Shares, 2021
    • 13.19.4. Product Benchmarking
    • 13.19.5. Recent Developments

14. Conclusion and Recommendations

  • 14.1. Concluding Remarks from Visiongain
  • 14.2. Recommendations for Market Players

List of Tables

  • Table 1: Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
  • Table 2: Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 3: Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
  • Table 4: Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 5: Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 6: Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 7: Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 8: Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 9: Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 10: Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 11: Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 12: Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 13: Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 14: Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 15: Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 16: Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 17: Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 18: Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 19: Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 20: Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 21: Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 22: Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 23: Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 24: Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 25: Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 26: Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 27: Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 28: Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 29: Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 30: Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 31: Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 32: Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 33: Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 34: Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 35: Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 36: Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 37: Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 38: Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 39: Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 40: Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 41: Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 42: Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 43: Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 44: Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 45: Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 46: Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 47: Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 48: Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 49: Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 50: Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 51: Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 52: Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 53: Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 54: Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 55: Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 56: Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 1: Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 57: Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 58: Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 59: Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 60: Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 61: Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 62: Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 63: Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 64: Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 65: Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 66: Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 67: Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 68: Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 69: Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 70: Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 71: Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 72: Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 73: Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 74: Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 75: North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 76: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 77: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 78: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 79: North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 80: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 81: North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 82: North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 83: North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 84: North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 85: North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 86: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 87: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 88: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 89: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 90: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 91: U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 92: U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 93: U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 94: U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 95: U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 96: Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 97: Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 98: Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 99: Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 100: Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 101: Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 102: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 103: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 104: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 105: Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 106: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 107: Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 108: Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 109: Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 110: Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 111: Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 112: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 113: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 114: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 115: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 116: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 117: Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 118: Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 119: Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 120: Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 121: Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 122: U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 123: U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 124: U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 125: U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 126: U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 127: France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 128: France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 129: France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 130: France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 131: France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 132: Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 133: Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 134: Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 135: Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 136: Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 137: Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 138: Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 139: Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 140: Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 141: Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 142: Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 143: Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 144: Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 145: Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 146: Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 147: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 148: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 149: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 150: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 151: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 152: Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 153: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 154: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 155: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 156: Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 157: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 158: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 159: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 160: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 161: Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 162: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 163: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 164: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 165: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 166: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 167: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 168: Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 169: Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 170: Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 171: Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 172: Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 173: China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 174: China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 175: China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 176: China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 177: China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 178: India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 179: India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 180: India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 181: India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 182: India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 183: Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 184: Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 185: Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 186: Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 187: Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 188: South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 189: South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 190: South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 191: South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 192: South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 193: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 194: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 195: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 196: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 197: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 198: Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 199: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 200: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 201: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 202: Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 203: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 204: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 205: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 206: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 207: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 208: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 209: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 210: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 211: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 212: Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 213: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 214: Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 215: Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 216: Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 217: Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 218: Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 219: Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 220: Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 221: Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 222: Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 223: Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 224: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 225: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 226: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 227: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 228: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 229: MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 230: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 231: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 232: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 233: MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 234: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 235: MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 236: MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 237: MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 238: MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 239: MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 240: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
  • Table 241: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 242: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 243: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 244: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 245: GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 246: GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 247: GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 248: GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 249: GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 250: South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 251: South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 252: South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 253: South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 254: South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 255: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
  • Table 256: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 257: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 258: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 259: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 260: Biologics Market Company Ranking for the Year 2021
  • Table 261: Biologics Market Recent Developments
  • Table 262: Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 263: Johnson & Johnson Services Inc.: Product Benchmarking
  • Table 264: Johnson & Johnson Services inc.: Recent Developments
  • Table 265: Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 266: Merck KGaA: Product Benchmarking
  • Table 267: Merck KGaA: Recent Developments
  • Table 268: GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 269: GlaxoSmithKline plc.: Product Benchmarking
  • Table 270: GlaxoSmithKline plc.: Recent Developments
  • Table 271: Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 272: Novartis AG: Product Benchmarking
  • Table 273: Novartis AG: Recent Developments
  • Table 274: F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 275: F. Hoffmann-La Roche Ltd: Product Benchmarking
  • Table 276: F. Hoffmann-La Roche Ltd: Recent Developments
  • Table 277: Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 278: Pfizer Inc.: Product Benchmarking
  • Table 279: Pfizer Inc.: Recent Developments
  • Table 280: Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 281: Sanofi: Product Benchmarking
  • Table 282: Sanofi: Recent Developments
  • Table 283: Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 284: Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
  • Table 285: Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
  • Table 286: Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 287: Takeda Pharmaceutical Company Limited: Product Benchmarking
  • Table 288: Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 289: Eli Lilly and Company: Product Benchmarking
  • Table 290: Eli Lilly and Company: Recent Developments
  • Table 291: Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 292: Amgen Inc.: Product Benchmarking
  • Table 293: Amgen Inc.: Recent Developments
  • Table 294: Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 295: Bristol-Myers Squibb Company: Product Benchmarking
  • Table 296: Bristol-Myers Squibb Company: Recent Developments
  • Table 297: Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 298: Biogen: Product Benchmarking
  • Table 299: Biogen: Recent Developments
  • Table 300: NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 301: NuVasive, Inc.: Product Benchmarking
  • Table 302: ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 303: ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
  • Table 304: Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 305: Organogenesis Holdings Inc. : Product Benchmarking
  • Table 306: Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 307: AbbVie Inc.: Product Benchmarking
  • Table 308: AbbVie Inc. : Recent Developments

List of Figures

  • Figure 1: Global Biologics Market Segmentation
  • Figure 2: Global Biologics Market: Market Dynamics
  • Figure 3: Global Biologics Market: SWOT Analysis
  • Figure 4: Global Biologics Market: Porter's Five Forces Analysis
  • Figure 5: Global Biologics Market: PEST Analysis
  • Figure 6: Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
  • Figure 7: Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
  • Figure 8: Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 9: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 10: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 11: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 12: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 13: Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 14: Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 15: Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 16: Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 17: Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 18: Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 19: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 20: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 21: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 22: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 23: Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 24: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 25: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 26: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 27: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 28: Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 29: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 30: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 31: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 32: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 33: Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
  • Figure 34: Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
  • Figure 35: Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 36: Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 37: Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 38: Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 39: Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 40: Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 41: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 42: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 43: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 44: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 45: Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 46: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 47: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 48: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 49: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 50: Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
  • Figure 51: Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 52: Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 53: Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 54: Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 55: Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 56: Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 57: Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 58: Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 59: Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 60: Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 61: Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 62: Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 63: Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 64: Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 65: Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
  • Figure 66: Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
  • Figure 67: Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 68: Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 69: Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 70: Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 71: Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 72: Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
  • Figure 73: Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 74: Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 75: Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 76: Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 77: Global Biologics Market Forecast by Region 2022-2032 (US$ billion)
  • Figure 78: Global Biologics Market Share Forecast by Region 2022, 2026, 2032 (%)
  • Figure 79: Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 80: Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 81: Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 82: Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 83: North America Biologics Market Forecast by Country 2022-2032 (US$ billion)
  • Figure 84: North America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
  • Figure 85: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
  • Figure 86: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 87: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 88: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 89: North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 90: North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
  • Figure 91: North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 92: North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 93: North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 94: North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 95: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
  • Figure 96: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 97: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 98: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 99: North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 100: U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 101: U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 102: U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 103: U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 104: U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 105: Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 106: Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 107: Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 108: Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 109: Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 110: Europe Biologics Market Forecast by Country 2022-2032 (US$ billion)
  • Figure 111: Europe Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
  • Figure 112: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
  • Figure 113: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 114: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 115: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 116: Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 117: Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
  • Figure 118: Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 119: Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 120: Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 121: Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 122: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
  • Figure 123: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 124: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 125: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 126: Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 127: Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 128: Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 129: Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 130: Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 131: Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 132: U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 133: U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 134: U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 135: U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 136: U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 137: France Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 138: France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 139: France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 140: France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 141: France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 142: Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 143: Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 144: Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 145: Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 146: Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 147: Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 148: Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 149: Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 150: Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 151: Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 152: Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 153: Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 154: Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 155: Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 156: Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 157: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 158: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 159: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 160: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 161: Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 162: Asia Pacific Biologics Market Forecast by Country 2022-2032 (US$ billion)
  • Figure 163: Asia Pacific Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
  • Figure 164: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
  • Figure 165: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 166: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 167: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 168: Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 169: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
  • Figure 170: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 171: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 172: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 173: Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 174: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
  • Figure 175: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 176: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 177: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 178: Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 179: Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 180: Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 181: Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 182: Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 183: Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 184: China Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 185: China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 186: China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 187: China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 188: China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 189: India Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 190: India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 191: India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 192: India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 193: India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 194: Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 195: Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 196: Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 197: Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 198: Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 199: South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 200: South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 201: South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 202: South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 203: South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 204: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 205: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 206: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 207: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 208: Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 209: Latin America Biologics Market Forecast by Country 2022-2032 (US$ billion)
  • Figure 210: Latin America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
  • Figure 211: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
  • Figure 212: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 213: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 214: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 215: Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 216: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
  • Figure 217: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 218: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 219: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 220: Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 221: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
  • Figure 222: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 223: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 224: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 225: Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 226: Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 227: Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 228: Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 229: Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 230: Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 231: Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 232: Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 233: Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 234: Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 235: Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 236: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 237: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 238: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 239: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 240: Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 241: MEA Biologics Market Forecast by Country 2022-2032 (US$ billion)
  • Figure 242: MEA Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
  • Figure 243: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
  • Figure 244: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 245: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 246: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 247: MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 248: MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
  • Figure 249: MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 250: MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 251: MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 252: MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 253: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
  • Figure 254: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 255: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 256: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 257: MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 258: GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 259: GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 260: GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 261: GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 262: GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 263: South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 264: South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 265: South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 266: South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 267: South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 268: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
  • Figure 269: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 270: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 271: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 272: Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 273: Johnson & Johnson Services Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 274: Johnson & Johnson Services Inc.: Regional Revenue Shares, 2021
  • Figure 275: Johnson & Johnson Services Inc.: Segmental Revenue Shares, 2021
  • Figure 276: Merck KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 277: Merck KGaA: Regional Revenue Shares, 2021
  • Figure 278: Merck KGaA: Segmental Revenue Shares, 2021
  • Figure 279: GlaxoSmithKline plc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 280: GlaxoSmithKline plc.: Regional Revenue Shares, 2021
  • Figure 281: GlaxoSmithKline plc.: Segmental Revenue Shares, 2021
  • Figure 282: Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 283: Novartis AG: Regional Revenue Shares, 2021
  • Figure 284: Novartis AG: Segmental Revenue Shares, 2021
  • Figure 285: F. Hoffmann-La Roche Ltd. : Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 286: F. Hoffmann-La Roche Ltd: Segmental Revenue Shares, 2021
  • Figure 287: F. Hoffmann-La Roche Ltd: Regional Revenue Shares, 2021
  • Figure 288: Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 289: Pfizer Inc.: Regional Revenue Shares, 2021
  • Figure 290: Pfizer Inc.: Segmental Revenue Shares, 2021
  • Figure 291: Sanofi: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 292: Sanofi: Regional Revenue Shares, 2021
  • Figure 293: Sanofi: Segmental Revenue Shares, 2021
  • Figure 294: Novo Holdings A/S (Novo Nordisk A/S): Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 295: Novo Holdings A/S (Novo Nordisk A/S): Regional Revenue Shares, 2020
  • Figure 296: Novo Holdings A/S (Novo Nordisk A/S): Segmental Revenue Shares, 2020
  • Figure 297: Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 298: Takeda Pharmaceutical Company Limited: Regional Revenue Shares, 2020
  • Figure 299: Takeda Pharmaceutical Company Limited: Segmental Revenue Shares, 2020
  • Figure 300: Eli Lilly and Company: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 301: Eli Lilly and Company: Regional Revenue Shares, 2020
  • Figure 302: Amgen Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 303: Amgen Inc.: Regional Revenue Shares, 2021
  • Figure 304: Amgen Inc.: Segment Revenue Shares, 2021
  • Figure 305: Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 306: Bristol-Myers Squibb Company: Regional Revenue Shares, 2021
  • Figure 307: Biogen: Net Revenue, 2017-2021 (US $ million, AGR %)
  • Figure 308: Biogen: Regional Revenue Shares, 2021
  • Figure 309: NuVasive, Inc.: Net Revenue, 2017-2021 (US $ million, AGR %)
  • Figure 310: NuVasive Inc.: Regional Revenue Shares, 2021
  • Figure 311: NuVasive Inc.: Segment Revenue Shares, 2021
  • Figure 312: ORTHOFIX INTERNATIONAL N.V. : Net Revenue, 2017-2021 (US $ million, AGR %)
  • Figure 313: ORTHOFIX INTERNATIONAL N.V. : Regional Revenue Shares, 2021
  • Figure 314: ORTHOFIX INTERNATIONAL N.V. : Segment Revenue Shares, 2020
  • Figure 315: Organogenesis Holdings Inc. : Net Revenue, 2018-2021 (US $ million, AGR %)
  • Figure 316: Organogenesis Holdings Inc. : Segment Revenue Shares, 2021
  • Figure 317: AbbVie Inc. : Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 318: AbbVie Inc. : Regional Revenue Shares, 2021
  • Figure 319: AbbVie Inc. : Segment Revenue Shares, 2021
  • Figure 320: Global Biologics Market Share Forecast by Region, 2022, 2026, 2032 (%)

List of Companies Profiled in the report:

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis AG
  • NuVasive, Inc.
  • Novo Holdings A/S (Novo Nordisk A/S)
  • Organogenesis Holdings Inc.
  • ORTHOFIX INTERNATIONAL N.V.
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited

List of Other Companies Mentioned in the report:

  • Abz-Pharma GmbH
  • Accord Healthcare Ltd
  • Alexion Pharmaceuticals Inc
  • AstraZeneca
  • Berlex Inc.
  • Biocon
  • BioPartners GmbH
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Celltech, UCB.
  • Celltrion Healthcare Hungary Kft.
  • Centocor Ortho Biotech Products LP
  • Chugai Pharmaceutical Co., Ltd
  • Coherus Biosciences
  • Dyax Corp.
  • Genmab A/S
  • Genzyme Corp.
  • Guardant Health
  • Hexal Ag
  • Hospira UK Limited
  • Janssen Biotech Inc
  • Kyowa Hakko Kirin
  • Medarex
  • Medice Arzneimittel Putter GmbH & Co. Kg
  • MedImmune
  • Millennium Pharmaceuticals Inc
  • Mylan
  • NovImmmune
  • Qiagen
  • Ratiopharm GmbH
  • Regeneron Pharmaceuticals
  • Samsung Bioepis
  • Sandoz GmbH
  • Stada Arzneimittel Ag
  • Sysmex Inostics
  • Taimed Biologics
  • Teva GmbH
  • United Therapeutics Corporation
  • Wyeth Pharmaceuticals
  • List of Organizations
  • Centers for Disease Control and Prevention (CDC)
  • Central Drug Standard Control Organization (CDSCO)
  • Centre for Pharmaceutical Administration Health Sciences Authority
  • European Medicines Agency (EMA)
  • European Union
  • Food and Drug Administration (FDA)
  • French Government
  • Government of Japan
  • Health Ministry (Italy)
  • Indian Council of Medical Research (ICMR)
  • Institute for Healthcare Improvement (IHI)
  • Italian Industry Group Farmindustria
  • Japanese Ministry of Health, Labour and Welfare
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Ministry of Health, Labour & Welfare(MHLW)
  • National Institute of Health (NIH)
  • NCBI
  • Organisation for Economic Co-operation and Development (OECD)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Statistical Office of the European Union (EUROSTAT)
  • United Nations (UN)
  • United Nations Statistics Division (UNSD)
  • World Health Organization (WHO)